FI20041340A0 - Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi - Google Patents

Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi

Info

Publication number
FI20041340A0
FI20041340A0 FI20041340A FI20041340A FI20041340A0 FI 20041340 A0 FI20041340 A0 FI 20041340A0 FI 20041340 A FI20041340 A FI 20041340A FI 20041340 A FI20041340 A FI 20041340A FI 20041340 A0 FI20041340 A0 FI 20041340A0
Authority
FI
Finland
Prior art keywords
risk
procedure
detecting
heart attack
test package
Prior art date
Application number
FI20041340A
Other languages
English (en)
Swedish (sv)
Inventor
Jukka T Salonen
Juha-Matti Aalto
Ricardo Fuentes
Outi Kontkanen
Mia Pirskanen
Pekka Uimari
Original Assignee
Jurilab Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jurilab Ltd Oy filed Critical Jurilab Ltd Oy
Priority to FI20041340A priority Critical patent/FI20041340A0/fi
Publication of FI20041340A0 publication Critical patent/FI20041340A0/fi
Priority to US11/143,642 priority patent/US20060099610A1/en
Priority to CA002584878A priority patent/CA2584878A1/en
Priority to JP2007536205A priority patent/JP2008516595A/ja
Priority to PCT/FI2005/050355 priority patent/WO2006040409A1/en
Priority to EP05797811A priority patent/EP1809764A1/en
Priority to AU2005293484A priority patent/AU2005293484A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI20041340A 2004-10-15 2004-10-15 Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi FI20041340A0 (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20041340A FI20041340A0 (fi) 2004-10-15 2004-10-15 Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi
US11/143,642 US20060099610A1 (en) 2004-10-15 2005-06-03 Method and kit for detecting a risk of acute myocardial infarction
CA002584878A CA2584878A1 (en) 2004-10-15 2005-10-12 Method and kit for detecting a risk of acute myocardial infarction
JP2007536205A JP2008516595A (ja) 2004-10-15 2005-10-12 急性心筋梗塞を発症する危険度を測定する方法とキット
PCT/FI2005/050355 WO2006040409A1 (en) 2004-10-15 2005-10-12 Method and kit for detecting a risk of acute myocardial infarction
EP05797811A EP1809764A1 (en) 2004-10-15 2005-10-12 Method and kit for detecting a risk of acute myocardial infarction
AU2005293484A AU2005293484A1 (en) 2004-10-15 2005-10-12 Method and kit for detecting a risk of acute myocardial infarction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20041340A FI20041340A0 (fi) 2004-10-15 2004-10-15 Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi

Publications (1)

Publication Number Publication Date
FI20041340A0 true FI20041340A0 (fi) 2004-10-15

Family

ID=33306034

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20041340A FI20041340A0 (fi) 2004-10-15 2004-10-15 Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi

Country Status (7)

Country Link
US (1) US20060099610A1 (fi)
EP (1) EP1809764A1 (fi)
JP (1) JP2008516595A (fi)
AU (1) AU2005293484A1 (fi)
CA (1) CA2584878A1 (fi)
FI (1) FI20041340A0 (fi)
WO (1) WO2006040409A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8388667B2 (en) * 2004-08-09 2013-03-05 Si-Bone, Inc. Systems and methods for the fixation or fusion of bone using compressive implants
US20070015170A1 (en) * 2005-07-12 2007-01-18 Oy Jurilab Ltd Method and kit for detecting a risk of coronary heart disease
WO2007131345A1 (en) * 2006-05-12 2007-11-22 The Hospital For Sick Children Genetic risk factor in sod1 and sfrs15 in renal disease, diabetic cataract, cardiovascular disease and longevity
WO2007136336A1 (en) * 2006-05-19 2007-11-29 Forskarpatent I Syd Ab Diagnosis of increased risk of acute myocardial infarction
JP5360855B2 (ja) * 2006-06-14 2013-12-04 雅嗣 田中 心筋梗塞に関する遺伝子検出方法
KR100818276B1 (ko) * 2006-09-27 2008-03-31 삼성전자주식회사 알콜 분해 능력과 숙취 발생 여부를 예측하기 위한프라이머 세트, 프로브 세트, 방법 및 키트
US7883851B2 (en) 2007-05-02 2011-02-08 Board Of Regents, The University Of Texas System Common allele on chromosome 9 associated with coronary heart disease
US8324368B2 (en) * 2008-12-10 2012-12-04 Alnylam Pharmaceuticals, Inc. GNAQ targeted dsRNA compositions and methods for inhibiting expression
ES2455124T5 (es) * 2010-05-05 2018-05-08 Zora Biosciences Oy Biomarcadores lipidómicos para la aterosclerosis y afección cardíaca
US9201080B2 (en) 2010-06-20 2015-12-01 Zora Biosciences Oy Lipidomic biomarkers for identification of high-risk coronary artery disease patients
US9910962B1 (en) * 2013-01-22 2018-03-06 Basehealth, Inc. Genetic and environmental risk engine and methods thereof
JP6622102B2 (ja) * 2016-02-04 2019-12-18 松森　昭 急性心筋梗塞の判定方法
US11414704B2 (en) * 2016-06-08 2022-08-16 University Of Iowa Research Foundation Compositions and methods for detecting predisposition to cardiovascular disease
JP7160748B2 (ja) * 2019-04-23 2022-10-25 ジェネシスヘルスケア株式会社 先天性心疾患のリスクを判定する方法
EP4041307A4 (en) * 2019-09-30 2023-10-18 Myome, Inc. POLYGENIC RISK SCORE FOR IN VITRO FERTILIZATION
CN111382392B (zh) * 2020-03-23 2023-04-18 国网江西省电力有限公司经济技术研究院 配电网故障处理总时间计算方法及其可靠性计算方法
KR20230150127A (ko) * 2022-04-21 2023-10-30 울산과학기술원 심근경색과 연관된 유전자 다형성 및 그의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1439189A2 (en) * 1997-06-13 2004-07-21 Human Genome Sciences, Inc. 86 Human Secreted Proteins
CN1347888A (zh) * 2000-10-11 2002-05-08 上海博德基因开发有限公司 一种新的多肽——小鼠plexin2蛋白207－17.93和编码这种多肽的多核苷酸
US20030032070A1 (en) * 2001-07-20 2003-02-13 Mt. Sinai School Of Medicine Methods for diagnosing and treating alzheimer's disease and parkinson's disease
CA2510895A1 (en) * 2002-12-20 2004-07-15 Applera Corporation Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
CA2511012C (en) * 2002-12-20 2018-02-27 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
EP1636379A2 (en) * 2003-06-26 2006-03-22 Exonhit Therapeutics S.A. Prostate specific genes and the use thereof as targets for prostate cancer therapy and diagnosis
EP1675962A2 (en) * 2003-10-16 2006-07-05 Novartis AG Differentially expressed genes related to coronary artery disease

Also Published As

Publication number Publication date
JP2008516595A (ja) 2008-05-22
EP1809764A1 (en) 2007-07-25
CA2584878A1 (en) 2006-04-20
US20060099610A1 (en) 2006-05-11
WO2006040409A1 (en) 2006-04-20
AU2005293484A1 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
FI20041340A0 (fi) Menetelmä ja testipakkaus äkillisen sydäninfarktin riskin havaitsemiseksi
FI20050011A (fi) Menetelmä ja testipakkaus tyypin 2 diabetes mellituksen riskin havaitsemiseksi
FI20060493A (fi) Menetelmä ja laitteisto kiinteistön valvontaa varten
DE602005017840D1 (de) Blutdruckmonitor
FI20070344A0 (fi) Testitapausten suorittamisen optimointimenetelmä ja -järjestelmä
FI20070180A (fi) Menetelmä ja laite pumpun suojaamiseksi käyttämättä perinteisiä antureita
FI20075390A0 (fi) Järjestely ja menetelmä joukkokorjuun mahdollistamiseksi
FI20041248A0 (fi) Menetelmä ja laitejärjestely päätelaitteen käyttöprofiilin hallitsemiseksi
FI20041490A0 (fi) Menetelmä ja testipakkaus olennaisesti kohonneen verenpaineen riskin havaitsemiseksi
FI20055231A (fi) Menetelmä ja mittalaite mitata vesipitoisuutta
FI20021643A0 (fi) Menetelmä pintajännityksen mittaamiseksi
FI20021783A0 (fi) Menetelmä kardiovaskulaaristen sairauksien riskin havaitsemiseksi
FI20021112A0 (fi) Menetelmä ja järjestely paikannuksen suorittamiseksi
FI20051027A (fi) Menetelmä ja laitteisto betonimassan valamiseksi
FI20065627A0 (fi) Laitteisto ja menetelmä aivojen toimintatilan määrittämistä varten
FI20022178A0 (fi) Menetelmä ja testipakkaus diabetesriskin havaitsemiseksi
FI20040395A0 (fi) Menetelmä paperinvalmistusprosessin monitoroimiseksi ja säätämiseksi
FI20041263A (fi) Menetelmä puintiajankohdan määrittämiseksi
SE0402157D0 (sv) Anordning för icke-invasiv bedömning av en vävnads vatteninnehåll
FI20075254A0 (fi) Menetelmä ja laite liikkujan etenemisen mittaamiseksi
FIU20040116U0 (fi) Järjestely puhkaisulujuuden mittaamiseksi
SE0602241L (sv) Anordning för detektering av blodläckage från sår
FI20000778A (fi) Menetelmä kardiovaskulaarisairausriskin detektoimiseksi
FI20041155A0 (fi) Menetelmä ja laite tautiriskin arvioimiseksi
FI20021461A0 (fi) Menetelmä ja järjestely puhkaisulujuuden mittaamiseksi

Legal Events

Date Code Title Description
FA Application withdrawn